S
Stockadora

Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4770 Reports
🤖 AI Analyzed
Recent
📄 Page 270 of 398
Gevo, Inc.
10-K March 5, 2026

Key Highlights

  • Strategic shift to high-value sustainable fuels (SAF) through divestiture of Agr...
  • Achieved 25% revenue growth in 2025, driven by acquisitions and increased enviro...
  • Significant progress towards commercial-scale SAF production with the Red Trail ...
Read Analysis
🤖 AI Generated
CorMedix Inc.
10-K March 5, 2026

Key Highlights

  • CorMedix experienced a transformative year in 2025 with the successful commercia...
  • DefenCath, the first FDA-approved preventative treatment for CRBSIs, demonstrate...
  • The acquisition of Melinta Therapeutics in August 2025 significantly expanded Co...
Read Analysis
🤖 AI Generated
Intrepid Potash, Inc.
10-K March 5, 2026

Key Highlights

  • Cash and cash equivalents more than doubled to $83.5 million in 2025, strengthen...
  • Generated robust cash flow from operating activities, increasing to $95.2 millio...
  • Maintains a $100 million unused revolving credit facility, indicating strong fin...
Read Analysis
🤖 AI Generated
Kura Oncology, Inc.
10-K March 5, 2026

Key Highlights

  • Kura Oncology is a clinical-stage biopharmaceutical company focused on discoveri...
  • Its lead product candidate, ziftomenib, is an investigational menin inhibitor cu...
  • The company's future outlook centers on advancing ziftomenib through later-stage...
Read Analysis
🤖 AI Generated
Silence Therapeutics plc
10-K March 5, 2026

Key Highlights

  • Advanced lead candidate SLN360 into Phase 3 clinical trials for high Lp(a).
  • Reported positive Phase 2 data for SLN124, with a pivotal study planned for 2026...
  • Secured a robust cash position of $320 million, providing a financial runway int...
Read Analysis
🤖 AI Generated
Ambiq Micro, Inc.
10-K March 5, 2026

Key Highlights

  • Successfully completed its Initial Public Offering (IPO) on July 31, 2025, raisi...
  • Achieved significant 35% revenue growth to $125 million in 2025, driven by stron...
  • Secured over 20 new design wins for its Apollo-series processors and maintains a...
Read Analysis
🤖 AI Generated
MONROE CAPITAL Corp
10-K March 5, 2026

Key Highlights

  • Net Investment Income (NII) of $2.15 per share, surpassing dividend payout.
  • Investment portfolio grew by 5% to $2.5 billion, driven by successful deployment...
  • Robust financial structure with $1.2 billion revolving credit facility and low 0...
Read Analysis
🤖 AI Generated
ADIAL PHARMACEUTICALS, INC.
10-K March 5, 2026

Key Highlights

  • Developing AD04 for Alcohol Use Disorder (AUD) in genetically-defined patients, ...
  • AD04 utilizes a low-dose version of ondansetron, an active ingredient already ap...
  • Actively exploring a strategic commercialization partnership with Molteni Farmac...
Read Analysis
🤖 AI Generated
STRATASYS LTD.
20-F March 5, 2026

Key Highlights

  • Stratasys, a global leader in 3D printing, reported $620 million in revenue for ...
  • The company maintains a strong financial position with $250 million in cash and ...
  • Strategic initiatives include collaborations with Nexa3D and Covestro, and dives...
Read Analysis
🤖 AI Generated
Wheeler Real Estate Investment Trust, Inc.
10-K March 5, 2026

Key Highlights

  • Strategic pivot to streamline portfolio, divesting numerous properties to reduce...
  • Net loss significantly narrowed and Funds From Operations (FFO) improved due to ...
  • Aggressive debt management, including substantial payments on existing loans and...
Read Analysis
🤖 AI Generated
Phio Pharmaceuticals Corp.
10-K March 5, 2026

Key Highlights

  • Developing new cancer immunotherapies using proprietary INTASYL™ technology.
  • Resilience in cybersecurity, with no major security incidents in the past three ...
  • Strategy focused on advancing lead product candidates through preclinical and cl...
Read Analysis
🤖 AI Generated
CrowdStrike Holdings, Inc.
10-K March 5, 2026

Key Highlights

  • CrowdStrike remains a dominant force in cybersecurity, demonstrating robust perf...
  • The company achieved non-GAAP profitability for the fiscal year ending January 3...
  • Strategic acquisitions (Pangea, Onum, Adaptive Shield, Flow Security) significan...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage